$AIMD

Taiwan Carbon Nano Technology Corp sold $97K of AIMD

Taiwan Carbon Nano Technology Corp sold 41,000 shares of Ainos, Inc. (AIMD) at $2.36 on 2026-05-26.

Original reporting
SEC EDGAR · Taiwan Carbon Nano Technology Corp
Published May 28, 2026, 12:00 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai May 28, 2026, 12:02 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$AIMD
Bearish
medium confidence
Mentioned
$AIMD
Relevance
7/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AIMDBearishMed
01

Why it matters

Traders may reassess near-term sentiment around AIMD due to insider selling, but the disclosed value (~$96.8K) suggests limited fundamental impact.

02

Market read

AIMD saw a modest open-market insider/10% owner sale; expect limited but potentially negative sentiment impact.

03

What to watch

No buy/sell context beyond this single transaction; also no information on total insider holdings changes beyond the post-sale balance.

Relevance 7/10Timing: Immediate (filed 2026-05-27, sale dated 2026-05-26); watch for same-day/next-day tape reaction.

Background

SEC Form 4 discloses a 10% owner’s open-market sale of Ainos (AIMD) shares; no pre-arranged 10b5-1 plan is indicated.

Company-level read

Ticker impact

$AIMDBearishMedium confidence
Context

Taiwan Carbon Nano Technology Corp, a 10% owner of Ainos, sold 41,000 AIMD shares for about $96.8K via an open-market sale.

Expected impact

Near-term bias to the downside/volatility, but magnitude likely limited given the modest dollar value.

Evidence & confidence

Form 4 shows an open-market sale of 41,000 shares at $2.36; without a stated 10b5-1 plan, traders may interpret as discretionary selling, yet the transaction size is relatively small versus typical market moves.

Market effects

Minimal—this is company-specific insider selling, not a sector-wide catalyst.

None indicated; filing is via SEC EDGAR for a US-listed issuer.

Low—no cross-border deal/regulatory/drug catalyst mentioned.

Counterpoint

The sale could be routine liquidity management; absence of a stated 10b5-1 plan does not necessarily imply negative outlook.

Key entities

  • Ainos, Inc.

    US-listed company whose shares were sold by a 10% owner via SEC Form 4.

  • Taiwan Carbon Nano Technology Corp

    10% owner of AIMD that sold 41,000 shares on 2026-05-26.

Related articles

$AIMDLow

Ainos, Inc. (AIMD): Results of Operations and Financial Condition

Ainos, Inc. (AIMD) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex99-1.htm EX-99.1 Exhibit 99.1 Ainos Reports Second Quarter 2026 Results and Highlights Continued AI Nose Execution Across Industrial, Healthcare Infrastructure and Robotics Markets Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) (“Ainos” or the “Company”) today announced resu

$AIMDMed

Ainos, Inc.: VASRO Research Highlights Ainos Smell AI Expansion into Emergency Department Operations

Ainos, Inc. (NASDAQ:AIMD) said VASRO GmbH highlighted its AI Nose platform’s expansion into live emergency department operations. VASRO reports a research program at an Asia academic medical center to generate 2,500+ hours of emergency-department environmental scent data for overcrowding early warning and respiratory infection risk analysis. The initiative broadens evaluations beyond industrial settings and supports Ainos’ Smell Language Model development.